Seres Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Seres Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Seres Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 314 %.
  • Seres Therapeutics, Inc. annual Return On Equity for 2023 was 534 %.
  • Seres Therapeutics, Inc. annual Return On Equity for 2022 was -549 %, a 1055% decline from 2021.
  • Seres Therapeutics, Inc. annual Return On Equity for 2021 was -47.5 %, a 68.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 534 +1.08K Jan 1, 2023 Dec 31, 2023
2022 -549 -501 -1055% Jan 1, 2022 Dec 31, 2022
2021 -47.5 +104 +68.6% Jan 1, 2021 Dec 31, 2021
2020 -151 -318 -191% Jan 1, 2020 Dec 31, 2020
2019 167 -317 -65.5% Jan 1, 2019 Dec 31, 2019
2018 484 +587 Jan 1, 2018 Dec 31, 2018
2017 -103 -46.6 -81.8% Jan 1, 2017 Dec 31, 2017
2016 -56.9 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.